This inventor holds 3 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Ctc Bio, Inc.. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jeollabuk-do, KR (2018 - 2019)
- Iksan-Si, KR (2021)
Company Filing History:
Years Active: 2018-2021
Title: Myeongcheol Kil: Innovator in Pharmaceutical Formulations
Introduction
Myeongcheol Kil is a notable inventor based in Jeollabuk-do, South Korea. He has made significant contributions to the field of pharmaceutical formulations, holding three patents that showcase his innovative approach to drug delivery systems.
Latest Patents
One of his latest patents is a tadalafil free base-containing film dosage form that utilizes polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as a dispersion stabilizer. This invention relates to a film formulation for oral administration, which maximizes the dispersion stability of tadalafil free base in the film. The addition of a dispersion stabilizing agent in small amounts minimizes the likelihood of a reagglomeration phenomenon of tadalafil free base particles and significantly reduces the amount of bubbles generated during the production process.
Another significant patent is a pharmaceutical preparation for masked taste oral administration containing clomipramine. This preparation comprises clomipramine or a pharmaceutically acceptable salt thereof, along with a cation exchange resin and an anion polymer as a taste masking agent. This innovation allows for the oral administration of clomipramine while effectively masking its unique bitter, spicy, and burning tastes, thereby improving the convenience of drug intake and portability.
Career Highlights
Myeongcheol Kil is currently associated with CTC Bio, Inc., where he continues to develop innovative pharmaceutical solutions. His work focuses on enhancing drug formulations to improve patient compliance and therapeutic outcomes.
Collaborations
He collaborates with talented coworkers, including Hong Ryeol Jeon and Do-Woo Kwon, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.
Conclusion
Myeongcheol Kil's contributions to pharmaceutical formulations demonstrate his commitment to improving drug delivery systems. His innovative patents reflect a deep understanding of the challenges in the field and a dedication to enhancing patient experiences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile